Inderjit Jabbal‐Gill
- Pharmaceutical Science top 0.2%
- Advanced Drug Delivery Systems 11
- Advancements in Transdermal Drug Delivery 2
- Immunology top 5%
- Immunotherapy and Immune Responses 5
- Immune Response and Inflammation 2
- Microbiology top 5%
- Bacterial Infections and Vaccines 4
- Biomaterials top 5%
- Molecular Medicine top 10%
-
- Influenza Virus Research Studies 4
-
- Inhalation and Respiratory Drug Delivery 4
-
- RNA Interference and Gene Delivery 2
Inderjit Jabbal‐Gill
20 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 103
- Pharmaceutical Science 1.1k
- Immunology 560
- Microbiology 159
- Biomaterials 319
- Molecular Medicine 66
Countries citing papers authored by Inderjit Jabbal‐Gill
This map shows the geographic impact of Inderjit Jabbal‐Gill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inderjit Jabbal‐Gill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inderjit Jabbal‐Gill more than expected).
Fields of papers citing papers by Inderjit Jabbal‐Gill
This network shows the impact of papers produced by Inderjit Jabbal‐Gill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inderjit Jabbal‐Gill. The network helps show where Inderjit Jabbal‐Gill may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Inderjit Jabbal‐Gill, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 31 | |
| 2 | 2012 | 81 | |
| 3 | 2011 | 27 | |
| 4 | 2010 | 70 | |
| 5 | 2005 | 40 | |
| 6 | 2005 | 145 | |
| 7 | 2005 | 27 | |
| 8 | 2003 | 104 | |
| 9 | 2003 | 98 | |
| 10 | 2003 | 86 | |
| 11 | 2002 | 113 | |
| 12 | 2002 | 217 | |
| 13 | 2001 | 86 | |
| 14 | 2001 | 24 | |
| 15 | Chitosan as a novel nasal delivery system for vaccinesbreakdown → | 2001 | 570 |
| 16 | 2000 | 122 | |
| 17 | 1999 | 41 | |
| 18 | 1998 | 100 | |
| 19 | 1991 | 28 | |
| 20 | 1982 | 4 |
About Inderjit Jabbal‐Gill
Inderjit Jabbal‐Gill is a scholar working on Pharmaceutical Science, Microbiology, Immunology, Epidemiology and Endocrine and Autonomic Systems, having authored 20 papers that have together received 2.0k indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (11 papers), Immunotherapy and Immune Responses (5 papers), Influenza Virus Research Studies (4 papers), Inhalation and Respiratory Drug Delivery (4 papers), Bacterial Infections and Vaccines (4 papers), Advancements in Transdermal Drug Delivery (2 papers), Immune Response and Inflammation (2 papers) and RNA Interference and Gene Delivery (2 papers). The work is most often cited by research in Pharmaceutical Science (1.1k citations), Immunology (560 citations), Microbiology (159 citations), Biomaterials (319 citations) and Molecular Medicine (66 citations). Inderjit Jabbal‐Gill has collaborated with scholars based in United Kingdom, Norway and Italy. Frequent co-authors include Lisbeth Illum, A.N. Fisher, M. Hinchcliffe, S.S. Davis, Peter Watts, Alan M. Smith, Richard Nankervis, S.S. Davis, Rino Rappuoli and A. M. Dyer. Their work appears in journals such as Vaccine, International Journal of Pharmaceutics, Influenza and Other Respiratory Viruses, Infection and Immunity and Advanced Drug Delivery Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.